ENSC 8-K 2026-07-15

Ensysce Biosciences, Inc. (ENSC) 8-K dated 2026-07-15 — accession 0001493152-26-033360. This URL is the filing, not the ENSC hub.

Ensysce Biosciences, Inc. (ENSC) is a biotechnology company listed on US.

Ensysce Biosciences, Inc. filed a 8-K on 2026-07-15. Accession 0001493152-26-033360.

Cached items: 5.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ENSC revenue for 2025-12-31 was $5.1M. Net income was -$10.2M. Revenue was down 2.8% from 2024-12-31 to 2025-12-31. ENSC currently screens at market cap $5.2M and trailing P/E 0.0.

Not investment advice. The ENSC SEC hub lists recent forms. The stock page is the research view.